Boston Scientific Corporation (BSX)
Boston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Boston Scientific (BSX). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical vs Boston Scientific: Which Stock Is the Better Buy Post Q1?
Intuitive Surgical's strong Q1 results, rising procedures, and raised outlook highlight accelerating growth, while Boston Scientific faces headwinds and tempered guidance.
Boston Scientific Just Slashed Guidance and Wall Street Followed. Is the Pullback a Buying Opportunity?
Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance on Wednesday.
Cwm LLC Has $3.49 Million Stock Holdings in Boston Scientific Corporation $BSX
Cwm LLC reduced its position in shares of Boston Scientific Corporation (NYSE: BSX) by 22.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,604 shares of the medical equipment provider's stock after selling 10,695 shares during the
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations
Expand NYSE: BSX Boston Scientific Today's Change (8.99%) $5.35 Current Price $64.87 Key Data Points Market Cap $88B Day's Range $61.78 - $65.32 52wk Range $59.38 - $109.50 Volume 40M Avg Vol 17M Gross Margin 65.04% Boston Scientific (BSX +8.99%), a medical device developer, closed Wednesday at $64.87, up 8.99%. The stock is jumping after a Q1 earnings beat paired with lowered 2026 guidance.
Boston Scientific Corporation (BSX) Q1 2026 Earnings Call Transcript
Boston Scientific Corporation (BSX) Q1 2026 Earnings Call Transcript
BSX Q1 Earnings Match, '26 View Down, Stock Gains in Premarket
Boston Scientific meets Q1 EPS estimates, posts 11.6% revenue growth and beats sales estimates, but cuts 2026 outlook; shares still climb in premarket trading.
Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Boston Scientific Slashes Guidance; Why Shares Rallied
Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.
Boston Scientific (BSX) Q1 Earnings Match Estimates
Boston Scientific (BSX) came out with quarterly earnings of $0.8 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.75 per share a year ago.
Boston Scientific cuts 2026 profit forecast, trims revenue growth view
Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a first-quarter earnings and revenue beat, while its shares were little changed after earlier volatility.
Boston Scientific Net Grows Sharply
Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, catheters and other cardiology devices.
